Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v1-EN
Language French English
Date Updated 2020-06-03 2020-04-22
Drug Identification Number 02244291 02244291
Brand name FLOVENT HFA FLOVENT HFA
Common or Proper name fluticasone propionate inhalation aerosol fluticasone propionate inhalation aerosol
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients FLUTICASONE PROPIONATE FLUTICASONE PROPIONATE
Strength(s) 50MCG 50MCG
Dosage form(s) METERED-DOSE AEROSOL METERED-DOSE AEROSOL
Route of administration INHALATION ORAL INHALATION ORAL INHALATION ORAL INHALATION ORAL
Packaging size 1x120 1x120
ATC code R03BA R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-04-22 2020-04-22
Estimated end date Unknown Unknown
Actual end date 2020-06-01
Shortage status Resolved Anticipated shortage
Company comments Re-supply is ongoing with inventory allocated to 100% of regular demand. Re-supply is ongoing with inventory allocated to 100% of regular demand.
Health Canada comments